A Case of Chronic Conjunctivitis following Rituximab Therapy

A Case of Chronic Conjunctivitis following Rituximab Therapy

The activity of the anti-CD20 monoclonal antibody, rituximab in B-cell non-Hodgkin's lymphoma, with relatively minimal toxicity has been well established. Adverse effects such as low-grade fever, urticaria, bronchospasm, sporadic tachycardia, and hypotension have been described. However, only a...

Full description

Bibliographic Details
Main Authors:	Marnelli A. Bautista, Walter D. Y. Quan, Jun Wang
Format:	Article
Language:	English
Published:	Hindawi Limited 2009-01-01
Series:	Advances in Hematology
Online Access:	http://dx.doi.org/10.1155/2009/272495

Similar Items

Follow-up data of rituximab as adjuvant therapy in pemphigus
by: Uday S Khopkar, et al.
Published: (2017-01-01)

Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
by: Mohamad Y. Khatib, et al.
Published: (2021-02-01)

Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
by: Hussein A. Nasir, et al.
Published: (2014-01-01)

Rituximab therapy for a severe case of pretibial myxedema
by: Amber Jimenez, BS, et al.
Published: (2021-04-01)

Rituximab Therapy for Primary Sjögren’s Syndrome
by: Yi Han Chen, et al.
Published: (2021-09-01)

Patterns of B Cell Repletion Following Rituximab Therapy in a Pediatric Rheumatology Cohort
by: Chace Mitchell, et al.
Published: (2019-10-01)

RITUXIMAB: NEW POTENTIALITIES OF THERAPY FOR RHEUMATOID ARTHRITIS
by: D E Karateev, et al.
Published: (2008-12-01)

Acute Bacterial Tenonitis and Conjunctivitis following Intravitreal Injection
by: Lillian Y. Huang, et al.
Published: (2021-04-01)

Rituximab as a rescue therapy in patients with glomerulonephritis
by: Muhammad Ziad Souqiyyeh, et al.
Published: (2015-01-01)

Rituximab Therapy in Pulmonary Alveolar Proteinosis: A Rare Case Report
by: Fatemeh Aghaei Meybodi, et al.
Published: (2018-04-01)

Rituximab for the treatment of patients with chronic lymphocytic leukemia
by: M Gentile, et al.
Published: (2010-03-01)

Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report
by: DaCosta J
Published: (2012-12-01)

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
by: Karan Seegobin, et al.
Published: (2021-03-01)

Pancytopenia following rituximab therapy in a patient with rheumatoid arthritis: Could filgrastim be a temporary solution?
by: Robin George Manappallil
Published: (2016-08-01)

Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial
by: Dena R Howard, et al.
Published: (2017-05-01)

Rituximab Iodination Procedure for Radioiodinated Rituximab (131I-Rituximab) Preparation
by: Martalena Ramli, et al.
Published: (2019-06-01)

Fatal Case of Enterovirus 71 Infection and Rituximab Therapy, France, 2012
by: Somar Kassab, et al.
Published: (2013-08-01)

Therapeutic Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection
by: Yaeni Kim, et al.
Published: (2014-06-01)

Rituximab combination therapy in relapsing multiple sclerosis
by: Anne H. Cross, et al.
Published: (2012-11-01)

Immunosuppressive therapy with rituximab in common variable immunodeficiency
by: Antonio Pecoraro, et al.
Published: (2019-05-01)

Rituximab therapy in Greek patients with rheumatoid arthritis
by: Haralampos M Moutsopoulos, et al.
Published: (2008-10-01)

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
by: Kanokrungsee S, et al.
Published: (2021-04-01)

Skin reactivity in allergic conjunctivitis
by: Pablo Andrés Miranda-Machado, et al.
Published: (2018-07-01)

Late-onset hypogammaglobulinemia after rituximab therapy
by: O V Moskalets
Published: (2019-12-01)

SPANISH CONJUNCTIONS AND CHINESE CONJUNCTIONS
by: CHOU,MEI MIAO, et al.
Published: (1995)

Critical Roles of Cytomegalovirus-Induced Natural Killer Cells in Chronic Hepatitis C Virus Infection and Rituximab-Mediated Cancer Therapy
by: Oh, Jun Seok
Published: (2017)

Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia
by: Aleem Aamer
Published: (2008-01-01)

A Case of M-Paraprotein-Associated Polyneuropathy with Stable Response to Rituximab Therapy
by: VG Potapenko, et al.
Published: (2019-09-01)

Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
by: Shuang Gao, et al.
Published: (2021-05-01)

Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
by: Francesco Autore, et al.
Published: (2020-06-01)

Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
by: J Dretzke, et al.
Published: (2010-10-01)

Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab
by: Kuwahara-Ota S, et al.
Published: (2018-05-01)

Bicker staffs encephlitis following acute haemorrhagic conjunctivitis
by: Dhir S, et al.
Published: (1984-01-01)

Rituximab for the therapy of systemic sclerosis: a series of 10 cases in a single center
by: Verônica Silva Vilela, et al.

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
by: Shah S, et al.
Published: (2015-08-01)

Marked deterioration in rheumatoid arthritis associated bronchiectasis following treatment with Rituximab
by: K. Musameh, et al.
Published: (2019-01-01)

Comparative efficacy of chronic lymphocytic leukemia treatment with or without rituximab
by: E. A. Zenkova, et al.
Published: (2019-12-01)

RITUXIMAB TREATMENT EFFICACY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS REFRACTORY TO STANDARD THERAPY IN THE LONG-TERM FOLLOW-UP
by: M. E. Tsanyan, et al.
Published: (2014-06-01)

The Conjunction Functions of the Particle tolko: A Conjunction Particle vs a Conjunction Analogue
by: Akopyan K. S.
Published: (2018-03-01)

Acquired double depressor palsy following acute haemorrhagic conjunctivitis
by: Prakash Prem, et al.
Published: (1988-01-01)